BenQ Medical Technology Corp.

As of June 30, 2026, BenQ Medical Technology Corp. carries a market capitalization of 1.72B, placing it among publicly traded companies globally. Its enterprise value stands at 3.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, BenQ Medical Technology Corp. has 44.57M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, BenQ Medical Technology Corp. maintains a current ratio of 1.52, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, BenQ Medical Technology Corp. recorded 100.29M in income tax expense.

As of the close on October 22, 2026, BenQ Medical Technology Corp.'s stock has declined approximately 15.67% over the past 52 weeks. The 50-day moving average sits at 39.70, while the 200-day moving average is 40.01.

As of June 30, 2026, BenQ Medical Technology Corp. holds 1.03B in cash and equivalents against 2.00B in total debt, resulting in a net debt position of 880.09M. Total book value stands at 1.10B, with working capital of 1.20B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

BenQ Medical Technology Corp.'s most recent stock split took place on October 6, 2008 with a 5:4 split ratio.